Bosutinib is a prescription medication used to treat adult patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). It is a type of drug known as a tyrosine kinase inhibitor (TKI). It works by blocking certain proteins that cancer cells need to survive and grow. Bosutinib is typically used after other TKI treatments have failed.
Bosutinib, sold under the brand name Bosutif, is a medication used to treat chronic myeloid leukemia (CML), a type of blood cancer that affects the bone marrow. Here's a detailed description:
How it works:
- Bosutinib belongs to a class of medications called tyrosine kinase inhibitors (TKIs). TKIs work by blocking the activity of specific enzymes called tyrosine kinases. These enzymes play a crucial role in the growth and survival of cancer cells.
- Bosutinib specifically targets a particular mutation (abnormal change) in the BCR-ABL gene, which is commonly found in individuals with CML. By blocking the activity of the abnormal BCR-ABL protein, Bosutinib helps to:
- Slow down the growth and division of cancer cells
- Induce cell death in cancer cells
What it's used for:
- Bosutinib is primarily used to treat adults with chronic phase, accelerated phase, or blast crisis CML who are:
- Resistant or intolerant to other TKI medications, such as imatinib (Gleevec). This means the cancer has not responded well to other treatments or caused unacceptable side effects.
- Newly diagnosed with CML in specific situations, when other TKIs are not suitable.
How it's used:
- Bosutinib is typically taken orally (by mouth) once a day, with or without food.
- The specific dosage is determined by the doctor based on individual factors, including:
- Overall health
- Body weight
- Response to treatment
- Other medications being taken
Important points to remember:
- Bosutinib is not a cure for CML but helps control the disease and improve symptoms.
- Common side effects can include:
- Diarrhea
- Nausea and vomiting
- Fatigue
- Rash
- Headache
- Abdominal pain
- Bosutinib can interact with other medications, so it is crucial to inform your doctor about all medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
- It is not recommended for everyone, especially pregnant or breastfeeding women, individuals with certain medical conditions, or those taking specific medications.
It is important to note that:
- I am not a medical professional and this information should not be taken as medical advice.
- Bosutinib is a prescription medication and should only be used under the supervision of a qualified healthcare professional, typically an oncologist specializing in blood cancers.
- Always consult your doctor about any questions or concerns you may have about Bosutinib or any other medication.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01E - Protein kinase inhibitors
L01EA BCR-ABL tyrosine kinase inhibitors
ATC Code
External Links
Bosutinib